{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:56:09Z","timestamp":1784285769738,"version":"3.55.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00108-020-00938-2","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T18:04:13Z","timestamp":1608573853000},"page":"111-120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Kontrastmittelinduzierte akute Nierensch\u00e4digung \u2013 Konsensuspapier der Arbeitsgemeinschaft \u201eHerz \u2013 Niere\u201c der Deutschen Gesellschaft f\u00fcr Kardiologie \u2013 Herz- und Kreislaufforschung e.\u202fV. und der Deutschen Gesellschaft f\u00fcr Nephrologie e.\u202fV.","Contrast medium-induced acute kidney injury\u2014Consensus paper of the working group \u201cHeart and Kidney\u201d of the German Cardiac Society and the German Society of Nephrology"],"prefix":"10.1007","volume":"62","author":[{"given":"J.","family":"Latus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Schwenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Schlieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Reinecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. B.","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. A.","family":"Remppis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Mahfoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,21]]},"reference":[{"key":"938_CR1","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.amjcard.2014.05.009","volume":"114","author":"M Abe","year":"2014","unstructured":"Abe\u00a0M, Morimoto\u00a0T, Akao\u00a0M et al (2014) Relation of contrast-induced nephropathy to long-term mortality after percutaneous coronary intervention. Am J Cardiol 114:362\u2013368. https:\/\/doi.org\/10.1016\/j.amjcard.2014.05.009","journal-title":"Am J Cardiol"},{"key":"938_CR2","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1172\/JCI117421","volume":"94","author":"Y Agmon","year":"1994","unstructured":"Agmon\u00a0Y, Peleg\u00a0H, Greenfeld\u00a0Z et\u00a0al (1994) Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J\u00a0Clin Invest 94:1069\u20131075. https:\/\/doi.org\/10.1172\/JCI117421","journal-title":"J Clin Invest"},{"key":"938_CR3","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/ki.2013.243","volume":"84","author":"KM Andrassy","year":"2013","unstructured":"Andrassy\u00a0KM (2013) Comments on \u201cKDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease\u201d. Kidney Int 84:622\u2013623. https:\/\/doi.org\/10.1038\/ki.2013.243","journal-title":"Kidney Int"},{"key":"938_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000504547","volume":"45","author":"G Aslan","year":"2020","unstructured":"Aslan\u00a0G, Afsar\u00a0B, Sag\u00a0AA et\u00a0al (2020) The effect of urine ph and urinary uric acid levels on the development of contrast nephropathy. Kidney Blood Press Res 45:131\u2013141. https:\/\/doi.org\/10.1159\/000504547","journal-title":"Kidney Blood Press Res"},{"key":"938_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ahj.2015.04.019","volume":"170","author":"KR Bainey","year":"2015","unstructured":"Bainey\u00a0KR, Rahim\u00a0S, Etherington\u00a0K et al (2015) Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: results from the angiotensin converting enzyme inhibitor\/angiotensin receptor bloc. Am Heart\u00a0J 170:110\u2013116. https:\/\/doi.org\/10.1016\/j.ahj.2015.04.019","journal-title":"Am Heart J"},{"key":"938_CR6","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.jcin.2015.07.012","volume":"8","author":"M Barbanti","year":"2015","unstructured":"Barbanti\u00a0M, Gulino\u00a0S, Capranzano\u00a0P et al (2015) Acute kidney injury with the renalguard system in patients undergoing transcatheter aortic valve replacement: the PROTECT-TAVI trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation). JACC Cardiovasc Interv 8:1595\u20131604. https:\/\/doi.org\/10.1016\/j.jcin.2015.07.012","journal-title":"JACC Cardiovasc Interv"},{"key":"938_CR7","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1161\/CIRCULATIONAHA.111.038943","volume":"124","author":"O Berwanger","year":"2011","unstructured":"Berwanger\u00a0O (2011) Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: Main results from the randomized acetylcysteine for contrast-induced nephropathy trial (ACT). Circulation 124:1250\u20131259. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.038943","journal-title":"Circulation"},{"key":"938_CR8","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/S0140-6736(14)60689-9","volume":"383","author":"SS Brar","year":"2014","unstructured":"Brar\u00a0SS, Aharonian\u00a0V, Mansukhani\u00a0P et al (2014) Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: The POSEIDON randomised controlled trial. Lancet 383:1814\u20131823. https:\/\/doi.org\/10.1016\/S0140-6736(14)60689-9","journal-title":"Lancet"},{"key":"938_CR9","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1161\/STROKEAHA.117.016771","volume":"48","author":"W Brinjikji","year":"2017","unstructured":"Brinjikji\u00a0W, Demchuk\u00a0AM, Murad\u00a0MH et\u00a0al (2017) Neurons over nephrons. Stroke 48:1862\u20131868. https:\/\/doi.org\/10.1161\/STROKEAHA.117.016771","journal-title":"Stroke"},{"key":"938_CR10","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2214\/AJR.08.1413","volume":"192","author":"RJ Bruce","year":"2009","unstructured":"Bruce\u00a0RJ, Djamali\u00a0A, Shinki\u00a0K et al (2009) Background fluctuation of kidney function versus contrast-induced nephrotoxicity. AJR Am J Roentgenol 192:711\u2013718. https:\/\/doi.org\/10.2214\/AJR.08.1413","journal-title":"AJR Am J Roentgenol"},{"key":"938_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.06.029","author":"DN Cruz","year":"2012","unstructured":"Cruz\u00a0DN, Goh\u00a0CY, Marenzi\u00a0G et al (2012) Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review. Am J Med. https:\/\/doi.org\/10.1016\/j.amjmed.2011.06.029","journal-title":"Am J Med"},{"key":"938_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.amjcard.2004.08.056","volume":"95","author":"G Dangas","year":"2005","unstructured":"Dangas\u00a0G, Iakovou\u00a0I, Nikolsky\u00a0E et al (2005) Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95:13\u201319. https:\/\/doi.org\/10.1016\/j.amjcard.2004.08.056","journal-title":"Am J Cardiol"},{"key":"938_CR13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1148\/radiol.12121394","volume":"267","author":"MS Davenport","year":"2013","unstructured":"Davenport\u00a0MS, Khalatbari\u00a0S, Dillman\u00a0JR et al (2013) Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material. Radiology 267:94\u2013105. https:\/\/doi.org\/10.1148\/radiol.12121394","journal-title":"Radiology"},{"key":"938_CR14","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1148\/radiol.2019192094","volume":"294","author":"MS Davenport","year":"2020","unstructured":"Davenport\u00a0MS, Perazella\u00a0MA, Yee\u00a0J et\u00a0al (2020) Use of intravenous iodinated contrast media in patients with kidney disease: Consensus statements from the American College of Radiology and the National Kidney Foundation. Radiology 294:660\u2013668. https:\/\/doi.org\/10.1148\/radiol.2019192094","journal-title":"Radiology"},{"key":"938_CR15","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1093\/ndt\/gfh868","volume":"20","author":"S Detrenis","year":"2005","unstructured":"Detrenis\u00a0S, Meschi\u00a0M, Musini\u00a0S, Savazzi\u00a0G (2005) Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art. Nephrol Dial Transplant 20:1542\u20131550. https:\/\/doi.org\/10.1093\/ndt\/gfh868","journal-title":"Nephrol Dial Transplant"},{"key":"938_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrneph.2016.196","volume":"13","author":"M F\u00e4hling","year":"2017","unstructured":"F\u00e4hling\u00a0M, Seeliger\u00a0E, Patzak\u00a0A, Persson\u00a0PB (2017) Understanding and preventing contrast-induced acute kidney injury. Nat Rev Nephrol 13:169\u2013180. https:\/\/doi.org\/10.1038\/nrneph.2016.196","journal-title":"Nat Rev Nephrol"},{"key":"938_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s00392-017-1166-2","volume":"107","author":"T Feldkamp","year":"2018","unstructured":"Feldkamp\u00a0T, Luedemann\u00a0M, Spehlmann\u00a0ME et\u00a0al (2018) Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures. Clin Res Cardiol 107:148\u2013157. https:\/\/doi.org\/10.1007\/s00392-017-1166-2","journal-title":"Clin Res Cardiol"},{"key":"938_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2215\/CJN.02590607","volume":"3","author":"S Fishbane","year":"2008","unstructured":"Fishbane\u00a0S (2008) N\u2011acetylcysteine in the prevention of contrast-induced nephropathy. Clin J Am Soc Nephrol 3:281\u2013287. https:\/\/doi.org\/10.2215\/CJN.02590607","journal-title":"Clin J Am Soc Nephrol"},{"key":"938_CR19","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.4065\/83.10.1095","volume":"83","author":"AM From","year":"2008","unstructured":"From\u00a0AM, Bartholmai\u00a0BJ, Williams\u00a0AW et\u00a0al (2008) Mortality associated with nephropathy after radiographic contrast exposure. Mayo Clin Proc 83:1095\u20131100. https:\/\/doi.org\/10.4065\/83.10.1095","journal-title":"Mayo Clin Proc"},{"key":"938_CR20","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1161\/CIRCINTERVENTIONS.114.002475","volume":"8","author":"D Giacoppo","year":"2015","unstructured":"Giacoppo\u00a0D, Madhavan\u00a0MV, Baber\u00a0U et al (2015) Impact of contrast-induced acute kidney injury after percutaneous coronary intervention on short- and long-term outcomes: Pooled analysis from the HORIZONS-AMI and ACUITY trials. Circ Cardiovasc Interv 8:2259\u20132264. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.114.002475","journal-title":"Circ Cardiovasc Interv"},{"key":"938_CR21","doi-asserted-by":"publisher","first-page":"e004675","DOI":"10.1161\/JAHA.116.004675","volume":"6","author":"LG Gilstrap","year":"2017","unstructured":"Gilstrap\u00a0LG, Fonarow\u00a0GC, Desai\u00a0AS et al (2017) Initiation, continuation, or withdrawal of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers and outcomes in patients hospitalized with heart failure with reduced ejection fraction. J\u00a0Am Heart Assoc 6:e4675. https:\/\/doi.org\/10.1161\/JAHA.116.004675","journal-title":"J Am Heart Assoc"},{"key":"938_CR22","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1097\/RCT.0000000000000624","volume":"41","author":"NM Gutierrez","year":"2017","unstructured":"Gutierrez\u00a0NM, Newhouse\u00a0JH (2017) Maximum arterial contrast concentrations with computed tomography and left ventriculography: implications for contrast nephrotoxicity risk. J\u00a0Comput Assist Tomogr 41:976\u2013982. https:\/\/doi.org\/10.1097\/RCT.0000000000000624","journal-title":"J Comput Assist Tomogr"},{"key":"938_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(18)32484-X","volume":"393","author":"BP Halliday","year":"2019","unstructured":"Halliday\u00a0BP, Wassall\u00a0R, Lota\u00a0AS et al (2019) Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet 393:61\u201373. https:\/\/doi.org\/10.1016\/S0140-6736(18)32484-X","journal-title":"Lancet"},{"key":"938_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1056\/NEJMoa1911481","volume":"382","author":"SS Hayek","year":"2020","unstructured":"Hayek\u00a0SS, Leaf\u00a0DE, Tahhan\u00a0AS et\u00a0al (2020) Soluble urokinase receptor and acute kidney injury. N\u00a0Engl J Med 382:416\u2013426. https:\/\/doi.org\/10.1056\/NEJMoa1911481","journal-title":"N Engl J Med"},{"key":"938_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh1069","author":"SN Heyman","year":"2005","unstructured":"Heyman\u00a0SN, Rosenberger\u00a0C, Rosen\u00a0S (2005) Regional alterations in renal haemodynamics and oxygenation: A role in contrast medium-induced nephropathy. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfh1069","journal-title":"Nephrol Dial Transplant"},{"key":"938_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.annemergmed.2016.11.021","volume":"69","author":"JS Hinson","year":"2017","unstructured":"Hinson\u00a0JS, Ehmann\u00a0MR, Fine\u00a0DM et\u00a0al (2017) Risk of acute kidney injury after intravenous contrast media administration. Ann Emerg Med 69:577\u2013586.e4. https:\/\/doi.org\/10.1016\/j.annemergmed.2016.11.021","journal-title":"Ann Emerg Med"},{"key":"938_CR27","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/ki.2010.258","volume":"78","author":"MT James","year":"2010","unstructured":"James\u00a0MT, Ghali\u00a0WA, Tonelli\u00a0M et al (2010) Acute kidney injury following coronary angiography is associated with a\u00a0long-term decline in kidney function. Kidney Int 78:803\u2013809. https:\/\/doi.org\/10.1038\/ki.2010.258","journal-title":"Kidney Int"},{"key":"938_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"JA Kellum","year":"2012","unstructured":"Kellum\u00a0JA, Lameire\u00a0N, Aspelin\u00a0P et\u00a0al (2012) Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1\u2013138. https:\/\/doi.org\/10.1038\/kisup.2012.1","journal-title":"Kidney Int Suppl"},{"key":"938_CR29","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1093\/eurheartj\/ehr501","volume":"33","author":"T Klima","year":"2012","unstructured":"Klima\u00a0T, Christ\u00a0A, Marana\u00a0I et al (2012) Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: a randomized controlled trial. Eur Heart\u00a0J 33:2071\u20132079. https:\/\/doi.org\/10.1093\/eurheartj\/ehr501","journal-title":"Eur Heart J"},{"key":"938_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2143\/AC.67.5.2174131","volume":"67","author":"DG Kong","year":"2012","unstructured":"Kong\u00a0DG, Hou\u00a0YF, Le Ma\u00a0L et al (2012) Comparison of oral and intravenous hydration strategies for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography or angioplasty: a randomized clinical trial. Acta Cardiol 67:565\u2013569. https:\/\/doi.org\/10.2143\/AC.67.5.2174131","journal-title":"Acta Cardiol"},{"key":"938_CR31","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/01.ASN.0000116241.47678.49","volume":"15","author":"AV Kshirsagar","year":"2004","unstructured":"Kshirsagar\u00a0AV, Poole\u00a0C, Mottl\u00a0A et al (2004) N\u2011Acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J\u00a0Am Soc Nephrol 15:761\u2013769. https:\/\/doi.org\/10.1097\/01.ASN.0000116241.47678.49","journal-title":"J Am Soc Nephrol"},{"key":"938_CR32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jacc.2013.04.105","volume":"63","author":"M Leoncini","year":"2014","unstructured":"Leoncini\u00a0M, Toso\u00a0A, Maioli\u00a0M et al (2014) Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: results from the PRATO-ACS study (protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome). J\u00a0Am Coll Cardiol 63:71\u201379. https:\/\/doi.org\/10.1016\/j.jacc.2013.04.105","journal-title":"J Am Coll Cardiol"},{"key":"938_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40256-016-0164-5","volume":"16","author":"H Li","year":"2016","unstructured":"Li\u00a0H, Wang\u00a0C, Liu\u00a0C et al (2016) Efficacy of short-term statin treatment for the prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography\/percutaneous coronary intervention: a meta-analysis of 21 randomized controlled trials. Am J Cardiovasc Drugs 16:201\u2013219. https:\/\/doi.org\/10.1007\/s40256-016-0164-5","journal-title":"Am J Cardiovasc Drugs"},{"key":"938_CR34","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1038\/sj.ki.5001887","volume":"70","author":"P Liss","year":"2006","unstructured":"Liss\u00a0P, Persson\u00a0PB, Hansell\u00a0P, Lagerqvist\u00a0B (2006) Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int 70:1811\u20131817. https:\/\/doi.org\/10.1038\/sj.ki.5001887","journal-title":"Kidney Int"},{"key":"938_CR35","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1007\/s11255-019-02235-w","volume":"51","author":"A Marashizadeh","year":"2019","unstructured":"Marashizadeh\u00a0A, Sanati\u00a0HR, Sadeghipour\u00a0P et al (2019) Left ventricular end-diastolic pressure-guided hydration for the prevention of contrast-induced acute kidney injury in patients with stable ischemic heart disease: the LAKESIDE trial. Int Urol Nephrol 51:1815\u20131822. https:\/\/doi.org\/10.1007\/s11255-019-02235-w","journal-title":"Int Urol Nephrol"},{"key":"938_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jcin.2011.08.017","volume":"5","author":"G Marenzi","year":"2012","unstructured":"Marenzi\u00a0G, Ferrari\u00a0C, Marana\u00a0I et\u00a0al (2012) Prevention of contrast nephropathy by furosemide with matched hydration: The MYTHOS (induced diuresis with matched hydration compared to standard hydration for contrast induced nephropathy prevention) trial. JACC Cardiovasc Interv 5:90\u201397. https:\/\/doi.org\/10.1016\/j.jcin.2011.08.017","journal-title":"JACC Cardiovasc Interv"},{"key":"938_CR37","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0002-9343(97)00150-2","volume":"103","author":"PA McCullough","year":"1997","unstructured":"McCullough\u00a0PA, Wolyn\u00a0R, Rocher\u00a0LL et\u00a0al (1997) Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 103:368\u2013375. https:\/\/doi.org\/10.1016\/S0002-9343(97)00150-2","journal-title":"Am J Med"},{"key":"938_CR38","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S0140-6736(17)30540-8","volume":"389","author":"PA McCullough","year":"2017","unstructured":"McCullough\u00a0PA, Zhang\u00a0J, Ronco\u00a0C (2017) Volume expansion and contrast-induced acute kidney injury. Lancet 389:1277\u20131278. https:\/\/doi.org\/10.1016\/S0140-6736(17)30540-8","journal-title":"Lancet"},{"key":"938_CR39","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.mayocp.2015.05.016","volume":"90","author":"JS McDonald","year":"2015","unstructured":"McDonald\u00a0JS, McDonald\u00a0RJ, Lieske\u00a0JC et\u00a0al (2015) Risk of acute kidney injury, dialysis, and mortality in patients with chronic kidney disease after intravenous contrast material exposure. Mayo Clin Proc 90:1046\u20131053. https:\/\/doi.org\/10.1016\/j.mayocp.2015.05.016","journal-title":"Mayo Clin Proc"},{"key":"938_CR40","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s00134-017-4699-y","volume":"43","author":"JS McDonald","year":"2017","unstructured":"McDonald\u00a0JS, McDonald\u00a0RJ, Williamson\u00a0EE et al (2017) Post-contrast acute kidney injury in intensive care unit patients: a\u00a0propensity score-adjusted study. Intensive Care Med 43:774\u2013784. https:\/\/doi.org\/10.1007\/s00134-017-4699-y","journal-title":"Intensive Care Med"},{"key":"938_CR41","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1148\/radiol.12121823","volume":"267","author":"RJ McDonald","year":"2013","unstructured":"McDonald\u00a0RJ, McDonald\u00a0JS, Bida\u00a0JP et al (2013) Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? Radiology 267:106\u2013118. https:\/\/doi.org\/10.1148\/radiol.12121823","journal-title":"Radiology"},{"key":"938_CR42","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.jacc.2004.06.068","volume":"44","author":"R Mehran","year":"2004","unstructured":"Mehran\u00a0R, Aymong\u00a0ED, Nikolsky\u00a0E et al (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J\u00a0Am Coll Cardiol 44:1393\u20131399. https:\/\/doi.org\/10.1016\/j.jacc.2004.06.068","journal-title":"J Am Coll Cardiol"},{"key":"938_CR43","doi-asserted-by":"publisher","first-page":"249810","DOI":"10.1155\/2014\/249810","volume":"2014","author":"A Michael","year":"2014","unstructured":"Michael\u00a0A, Faga\u00a0T, Pisani\u00a0A et\u00a0al (2014) Molecular mechanisms of renal cellular nephrotoxicity due to radiocontrast media. Biomed Res Int 2014:249810. https:\/\/doi.org\/10.1155\/2014\/249810","journal-title":"Biomed Res Int"},{"key":"938_CR44","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1007\/s003300050894","volume":"9","author":"SK Morcos","year":"1999","unstructured":"Morcos\u00a0SK, Thomsen\u00a0HS, Webb\u00a0JAW (1999) Contrast-media-induced nephrotoxicity: a consensus report. Eur Radiol 9:1602\u20131613. https:\/\/doi.org\/10.1007\/s003300050894","journal-title":"Eur Radiol"},{"key":"938_CR45","doi-asserted-by":"publisher","first-page":"376","DOI":"10.2214\/AJR.07.3280","volume":"191","author":"JH Newhouse","year":"2008","unstructured":"Newhouse\u00a0JH, Kho\u00a0D, Rao\u00a0QA, Starren\u00a0J (2008) Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol 191:376\u2013382. https:\/\/doi.org\/10.2214\/AJR.07.3280","journal-title":"AJR Am J Roentgenol"},{"key":"938_CR46","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/RLI.0000000000000479","volume":"53","author":"EC Nijssen","year":"2018","unstructured":"Nijssen\u00a0EC, Nelemans\u00a0PJ, Rennenberg\u00a0RJ et\u00a0al (2018) Evaluation of safety guidelines on the use of Iodinated contrast material: conundrum continued. Invest Radiol 53:616\u2013622. https:\/\/doi.org\/10.1097\/RLI.0000000000000479","journal-title":"Invest Radiol"},{"key":"938_CR47","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/S0140-6736(17)30057-0","volume":"389","author":"EC Nijssen","year":"2017","unstructured":"Nijssen\u00a0EC, Rennenberg\u00a0RJ, Nelemans\u00a0PJ et al (2017) Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a\u00a0prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet 389:1312\u20131322. https:\/\/doi.org\/10.1016\/S0140-6736(17)30057-0","journal-title":"Lancet"},{"key":"938_CR48","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1177\/2045893217716108","volume":"7","author":"JM O\u2019Leary","year":"2017","unstructured":"O\u2019Leary\u00a0JM, Assad\u00a0TR, Xu\u00a0M et\u00a0al (2017) Pulmonary hypertension in patients with chronic kidney disease: Invasive hemodynamic etiology and outcomes. Pulm Circ 7:674\u2013683. https:\/\/doi.org\/10.1177\/2045893217716108","journal-title":"Pulm Circ"},{"key":"938_CR49","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jcin.2019.11.021","volume":"13","author":"A Panagiotou","year":"2020","unstructured":"Panagiotou\u00a0A, Trendelenburg\u00a0M, Heijnen\u00a0IAFM et al (2020) A randomized trial of recombinant human C1-esterase-inhibitor in the prevention of contrast-induced kidney injury. JACC Cardiovasc Interv 13:833\u2013842. https:\/\/doi.org\/10.1016\/j.jcin.2019.11.021","journal-title":"JACC Cardiovasc Interv"},{"key":"938_CR50","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1053\/j.ajkd.2019.06.011","volume":"75","author":"CR Parikh","year":"2020","unstructured":"Parikh\u00a0CR, Liu\u00a0C, Mor\u00a0MK et al (2020) Kidney biomarkers of injury and repair as predictors of contrast-associated AKI: a substudy of the PRESERVE trial. Am J Kidney Dis 75:187\u2013194. https:\/\/doi.org\/10.1053\/j.ajkd.2019.06.011","journal-title":"Am J Kidney Dis"},{"key":"938_CR51","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1038\/sj.ki.5000367","volume":"69","author":"PB Persson","year":"2006","unstructured":"Persson\u00a0PB, Tepel\u00a0M (2006) Contrast medium-induced nephropathy: the pathophysiology. Kidney Int 69:S8\u2013S10. https:\/\/doi.org\/10.1038\/sj.ki.5000367","journal-title":"Kidney Int"},{"key":"938_CR52","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1161\/01.CIR.0000016043.87291.33","volume":"105","author":"CS Rihal","year":"2002","unstructured":"Rihal\u00a0CS, Textor\u00a0SC, Grill\u00a0DE et\u00a0al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259\u20132264. https:\/\/doi.org\/10.1161\/01.CIR.0000016043.87291.33","journal-title":"Circulation"},{"key":"938_CR53","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/ki.1995.32","volume":"47","author":"MR Rudnick","year":"1995","unstructured":"Rudnick\u00a0MR, Goldfarb\u00a0S, Wexler\u00a0L et\u00a0al (1995) Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a\u00a0randomized trial. The Iohexol Cooperative Study. Kidney Int 47:254\u2013261","journal-title":"Kidney Int"},{"key":"938_CR54","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1253\/circj.CJ-14-1345","volume":"79","author":"Y Saito","year":"2015","unstructured":"Saito\u00a0Y, Watanabe\u00a0M, Aonuma\u00a0K et al (2015) Proteinuria and reduced estimated glomerular filtration rate are independent risk factors for contrast-induced nephropathy after cardiac catheterization. Circ\u00a0J 79:1624\u20131630. https:\/\/doi.org\/10.1253\/circj.CJ-14-1345","journal-title":"Circ J"},{"key":"938_CR55","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1148\/radiol.2019182220","volume":"292","author":"E Sch\u00f6nenberger","year":"2019","unstructured":"Sch\u00f6nenberger\u00a0E, Martus\u00a0P, Bosserdt\u00a0M et al (2019) Kidney injury after intravenous versus intra-arterial contrast agent in patients suspected of having coronary artery disease: a randomized trial. Radiology 292:664\u2013672. https:\/\/doi.org\/10.1148\/radiol.2019182220","journal-title":"Radiology"},{"key":"938_CR56","doi-asserted-by":"publisher","first-page":"358136","DOI":"10.1155\/2014\/358136","volume":"2014","author":"E Seeliger","year":"2014","unstructured":"Seeliger\u00a0E, Lenhard\u00a0DC, Persson\u00a0PB (2014) Contrast media viscosity versus osmolality in kidney injury: lessons from animal studies. Biomed Res Int 2014:358136. https:\/\/doi.org\/10.1155\/2014\/358136","journal-title":"Biomed Res Int"},{"key":"938_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.11453","author":"KA McLean","year":"2020","unstructured":"STARSurg Collaborative, McLean\u00a0KA, Ahmed\u00a0WUR, Akhbari\u00a0M et\u00a0al (2020) Perioperative intravenous contrast administration and the incidence of acute kidney injury after major gastrointestinal surgery: prospective, multicentre cohort study. Br J Surg. https:\/\/doi.org\/10.1002\/bjs.11453","journal-title":"Br J Surg"},{"key":"938_CR58","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0735-1097(98)00574-9","volume":"33","author":"MA Stevens","year":"1999","unstructured":"Stevens\u00a0MA, McCullough\u00a0PA, Tobin\u00a0KJ et\u00a0al (1999) A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: Results of the P.R.I.N.C.E. study. J\u00a0Am Coll Cardiol 33:403\u2013411. https:\/\/doi.org\/10.1016\/S0735-1097(98)00574-9","journal-title":"J Am Coll Cardiol"},{"key":"938_CR59","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.2215\/CJN.00710113","volume":"8","author":"P Susantitaphong","year":"2013","unstructured":"Susantitaphong\u00a0P, Cruz\u00a0DN, Cerda\u00a0J et al (2013) World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol 8:1482\u20131493. https:\/\/doi.org\/10.2215\/CJN.00710113","journal-title":"Clin J Am Soc Nephrol"},{"key":"938_CR60","doi-asserted-by":"publisher","first-page":"C29","DOI":"10.1159\/000066641","volume":"93","author":"HS Trivedi","year":"2003","unstructured":"Trivedi\u00a0HS, Moore\u00a0H, Nasr\u00a0S et\u00a0al (2003) A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93:C29\u2013C34. https:\/\/doi.org\/10.1159\/000066641","journal-title":"Nephron Clin Pract"},{"key":"938_CR61","doi-asserted-by":"publisher","first-page":"e001380","DOI":"10.1161\/JAHA.114.001380","volume":"3","author":"TT Tsai","year":"2014","unstructured":"Tsai\u00a0TT, Patel\u00a0UD, Chang\u00a0TI et al (2014) Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: Insights from the National Cardiovascular Data Registry Cath-PCI registry. J\u00a0Am Heart Assoc 3:e1380. https:\/\/doi.org\/10.1161\/JAHA.114.001380","journal-title":"J Am Heart Assoc"},{"key":"938_CR62","doi-asserted-by":"publisher","first-page":"e004439","DOI":"10.1161\/CIRCINTERVENTIONS.116.004439","volume":"10","author":"JA Valle","year":"2017","unstructured":"Valle\u00a0JA, McCoy\u00a0LA, Maddox\u00a0TM et\u00a0al (2017) Longitudinal risk of adverse events in patients with acute kidney injury after percutaneous coronary intervention. Circ Cardiovasc Interv 10:e4439. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.116.004439","journal-title":"Circ Cardiovasc Interv"},{"key":"938_CR63","doi-asserted-by":"publisher","first-page":"e1658","DOI":"10.4244\/EIJV11I14A317","volume":"11","author":"G Visconti","year":"2016","unstructured":"Visconti\u00a0G, Focaccio\u00a0A, Donahue\u00a0M et\u00a0al (2016) RenalGuard System for the prevention of acute kidney injury in patients undergoing transcatheter aortic valve implantation. EuroIntervention 11:e1658\u2013e1661. https:\/\/doi.org\/10.4244\/EIJV11I14A317","journal-title":"EuroIntervention"},{"key":"938_CR64","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S0002-9343(01)00983-4","volume":"111","author":"B Vogt","year":"2001","unstructured":"Vogt\u00a0B, Ferrari\u00a0P, Sch\u00f6nholzer\u00a0C et\u00a0al (2001) Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 111:692\u2013698. https:\/\/doi.org\/10.1016\/S0002-9343(01)00983-4","journal-title":"Am J Med"},{"key":"938_CR65","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1681\/ASN.2006030301","volume":"17","author":"SD Weisbord","year":"2006","unstructured":"Weisbord\u00a0SD, Chen\u00a0H, Stone\u00a0RA et\u00a0al (2006) Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. J\u00a0Am Soc Nephrol 17:2871\u20132877. https:\/\/doi.org\/10.1681\/ASN.2006030301","journal-title":"J Am Soc Nephrol"},{"key":"938_CR66","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1710933","volume":"378","author":"SD Weisbord","year":"2018","unstructured":"Weisbord\u00a0SD, Gallagher\u00a0M, Jneid\u00a0H et\u00a0al (2018) Outcomes after angiography with sodium bicarbonate and acetylcysteine. N\u00a0Engl J Med 378:603\u2013614. https:\/\/doi.org\/10.1056\/NEJMoa1710933","journal-title":"N Engl J Med"},{"key":"938_CR67","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1681\/ASN.2016010021","volume":"28","author":"E Wilhelm-Leen","year":"2017","unstructured":"Wilhelm-Leen\u00a0E, Montez-Rath\u00a0ME, Chertow\u00a0G (2017) Estimating the risk of radiocontrast-associated nephropathy. J\u00a0Am Soc Nephrol 28:653\u2013659. https:\/\/doi.org\/10.1681\/ASN.2016010021","journal-title":"J Am Soc Nephrol"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-020-00938-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-020-00938-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-020-00938-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T16:42:54Z","timestamp":1611160974000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-020-00938-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,21]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["938"],"URL":"https:\/\/doi.org\/10.1007\/s00108-020-00938-2","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,21]]},"assertion":[{"value":"21 December 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Felix Mahfoud gibt an, Forschungsunterst\u00fctzung und Vortragshonorare von Medtronic, Recor, Berlin Chemie und Boehringer Ingelheim erhalten zu haben und durch die Deutsche Forschungsgemeinschaft (SFB-TRR219) unterst\u00fctzt zu werden. J.\u00a0Latus, V.\u00a0Schwenger, G.\u00a0Schlieper, H.\u00a0Reinecke, J.\u00a0Hoyer, P.B.\u00a0Persson und B.A.\u00a0Remppis geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}